Concepedia
Statistics
Publications
18
Citations
497
H-Index
14
Active since
2001
Affiliations
Uppsala University(Current)
Uppsala University Hospital
Umeå University
Karolinska University Hospital
Karolinska Institutet
Anna Åleskog is an author at Uppsala University specializing in medicine, oncology, and pharmacology.
Publications per year
2001–2011
Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status
Pawel Grabowski, Magnus Hultdin, Karin Karlsson et al. · Blood · 2005 · 116 citations · Full text
Medicine, Hematology, Oncology +17
In vitro evaluation of clinical activity and toxicity of anticancer drugs using tumor cells from patients and cells representing normal tissues
Caroline Haglund, Anna Åleskog, Peter Nygren et al. · Cancer Chemotherapy and Pharmacology · 2011 · 39 citations
Medicine, Oncology, Pharmacology +17
Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome.
Gerard Tobin, Ulf Thunberg, Anna Laurell et al. · PubMed · 2005 · 37 citations
The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia
Å Skogsberg, Gerard Tobin, Alexander Kröber et al. · Leukemia · 2005 · 36 citations
Life Sciences, Genetics, Molecular Genetics +6
Significant cytotoxic activity <i>in vitro</i> of the EGFR tyrosine kinase inhibitor gefitinib in acute myeloblastic leukaemia
Elin Lindhagen, Anna Eriksson, Malin Wickström et al. · European Journal Of Haematology · 2008 · 31 citations · Full text
Medicine, Oncology, Pharmacology +15
1–5 of 18